What Is the Best Anxiety Medication for Men?

What is the best medication for anxiety in men?

The best medication for anxiety in men is the one that fits the person’s symptoms, medical situation, preferences, and experience of side effects. Medication is one part of treatment: the National Institute of Mental Health (NIMH) says generalized anxiety disorder may be treated with psychotherapy, medication, or both, and finding a suitable plan can take trial and error.

For ongoing anxiety, clinicians commonly consider SSRIs or SNRIs. These antidepressants are used for anxiety, but they do not provide instant relief. NIMH says they usually take 4–8 weeks to work. Headache, nausea, trouble sleeping, and sexual dysfunction are among the possible side effects; a clinician may use a low starting dose and gradual increases to help manage some effects.

Buspirone is another daily option. It is not a sedative and has less potential for addiction than benzodiazepines, according to NIMH. It generally takes 3–4 weeks to reach full effect and does not work when taken only as needed.

Benzodiazepines have a different role. They can reduce severe anxiety rapidly, but tolerance and dependence are concerns with longer-term use. NIMH says clinicians generally prescribe them for short periods and taper them gradually when needed. The distinction is practical: daily medicines aim to reduce anxiety over time, while benzodiazepines may be used for short-term relief under clinical supervision.

Choice is not a contest between drug names. It depends on what symptoms need treatment, other health conditions and medicines, prior responses, access, and the side effects a person most wants to avoid. This is also why a medicine that suits one man may not suit another.

Is Lexapro or Zoloft better for men with anxiety?

Available evidence does not establish Lexapro or Zoloft as universally better for men with anxiety. A U.S. Department of Defense Psychological Health Center of Excellence review identifies escitalopram (Lexapro) as FDA-approved for generalized anxiety disorder (GAD) in the United States, while sertraline (Zoloft) is commonly used off label for GAD.

The same review reports no head-to-head differences between individual SSRIs in recent cited network meta-analyses. That does not prove the medicines are identical for every person; it means those comparisons do not settle which one is best for an individual. The review points to patient preference, clinician competence, and treatment availability as factors in selection.

A BMJ systematic review of adult GAD medication trials found few significant differences among active treatments for response and remission. In a subanalysis of medicines licensed for GAD in the United Kingdom, escitalopram ranked highest for remission; in the broader analysis, sertraline ranked highest for fewer withdrawals due to adverse events. Those rankings depend on the analysis and available evidence. They are not a personal prediction or a universal winner.

GAD is not the only kind of anxiety, and medication is not selected by gender alone. Men discussing treatment can name the problems they want addressed—such as persistent worry, sleep problems, or difficulty concentrating—and describe any past medication effects. NIMH notes that treatment choice is based on a person’s needs, preferences, and medical situation.

Which anxiety medications are less likely to affect erections, libido, or orgasm?

No option in the supplied evidence can be called reliably free of sexual effects for every man. SSRIs can be associated with delayed ejaculation, reduced desire, reduced sexual satisfaction, difficulty reaching orgasm, and erectile difficulties, according to a review in The Mental Health Clinician. The effect to watch for is broader than erection alone.

That review describes variation across medicines and studies. In one prospective study of 344 people discussed by the authors, reported sexual side effects were most frequent with paroxetine, followed by fluvoxamine, sertraline, and fluoxetine. The review also notes that higher SSRI doses were associated with more frequent side effects in cited studies, and that clinicians found them more often when they asked directly than when patients reported them without prompting. These findings do not rank every anxiety treatment or predict an individual outcome.

A systematic review in Archives of Medical Science examined SSRI-associated sexual dysfunction in men treated for major depressive disorder, not anxiety. It reported treatment-emergent sexual dysfunction, particularly erectile dysfunction, but found the evidence insufficient to establish a strong link between SSRIs and erectile dysfunction or to precisely compare individual SSRIs. The review’s population and evidence limits matter when applying its findings to anxiety treatment.

Sexual health can be part of the medication conversation from the start. A direct question about desire, erections, ejaculation, or orgasm gives the prescriber a baseline for follow-up. If a change develops or persists, the review in The Mental Health Clinician describes clinician-supervised options such as adjusting treatment or switching medication. Do not change or stop a prescribed medicine on your own: NIMH advises consulting a provider before stopping, and some medicines need gradual tapering.

For a wider comparison of side-effect tradeoffs, see Best Anxiety Medication With Least Side Effects: What Is It? The useful question is not only which medicine has fewer reported effects, but which tradeoffs matter for the person taking it and how they will be monitored.